Header Logo

Connection

LAURA PETERSEN to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications LAURA PETERSEN has written about Antibodies, Monoclonal.
LAURA PETERSEN
Connection Strength
0.092
Antibodies, Monoclonal
  1. Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs. Circulation. 2017 06 20; 135(25):2572-2574.
    View in: PubMed
    Score: 0.092
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.